LinzagolixHormone TherapySafety Rating 7/10
Primary research areaUterine fibroids pain management
Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.
Research dose range100-200 mg once daily
AdministrationOral tablet
Safety7/10 · EMA-approved (Yselty)
NCAA D1Banned
Price Comparison
Compare vendors
No vendor pricing available for this peptide yet.
Overview
About Linzagolix
Mechanism of action
Oral GnRH receptor antagonist; partial or complete estrogen suppression
Safety profile
Hot flashes, headache, bone density changes · Approved in EU for uterine fibroids; bone density monitoring; newer but well-studied
🔔 Get notified when the price drops anywhere
No account required. We scan 30+ vendors daily — one email the moment any vendor drops Linzagolix below your target.
Related pages